Fontan-associated liver disease (FALD) is a universal complication of patients with Fontan physiology with increasing clinical relevance. The optimal management of FALD, including screening for complications such as portal hypertension and HCC, remains poorly defined. Additionally, the role of transplantation (heart-only versus combined liver-heart) is complex. Experts in this session discuss both the medical and surgical complexities of FALD and outline opportunities for future collaborative efforts.